FREQUENCY OF POST-CORONARY ARTERY BYPASS GRAFT (CABG) THROMBOCYTOPENIA AND ITS ASSOCIATED COMPLICATIONS
Main Article Content
Keywords
Thrombocytopenia, Coronary Artery Bypass Grafting, Cardiopulmonary Bypass, Platelet Count, Postoperative Complications
Abstract
Background: A frequent hematological side effect after coronary artery bypass grafting (CABG), especially in patients having cardiopulmonary bypass (CPB), is thrombocytopenia. Although its precise prognostic importance is still up for debate, severe thrombocytopenia may put patients at risk for complications like stroke, acute kidney damage (AKI), and bleeding. The purpose of this study was to ascertain the prevalence of thrombocytopenia following CABG and evaluate its correlation with significant postoperative complications in a Pakistani tertiary cardiac institution.
Methods: From June to December 2022, a descriptive case series was carried out at the Rehman Medical Institute in Peshawar. Non-probability consecutive sampling was used to enroll seventy-four adult patients undergoing urgent or elective isolated CABG. A platelet count <150×10⁹/L on any postoperative day was considered thrombocytopenia, which was further divided into three categories: mild (100–149×10⁹/L), moderate (50–99×10⁹/L), and severe (<50×10⁹/L). On the first, second, third, fourth, fifth, and ten postoperative days, platelet levels were tracked. Significant bleeding, AKI (according to KDIGO criteria), and stroke were among the complications noted. SPSS v25.0 was used to analyze the data, and p<0.05 was deemed significant.
Results: Patients were 56.7±5.9 years old on average, and 67.6% of them were men. 16.2% (n=12) of patients had thrombocytopenia, with mild cases accounting for 5.4%, moderate cases for 6.8%, and severe cases for 4.1%. AKI (1.4%), stroke (1.4%), and re-exploration for bleeding (4.1%) were among the complications. Neither complications nor demographic factors were found to be statistically associated with thrombocytopenia.
Conclusion: 16.2% of patients experienced post-CABG thrombocytopenia, with mild to moderate cases accounting for the majority of cases. Thrombocytopenia demonstrated a clinical trend toward more postoperative problems, although this trend was not statistically significant. For better risk stratification, routine postoperative platelet monitoring is advised, as are upcoming research projects that use dynamic platelet indices.
References
2. Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease. J Am Coll Cardiol. 2014;64(18):1929-49.
3. Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the SYNTAX trial. Lancet. 2013;381(9867):629-38.
4. Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization. Circulation. 2022;145(3):e18-e114.
5. McDonald CI, Fraser JF, Coombes JS, et al. Oxidative stress during extracorporeal circulation. Eur J Cardiothorac Surg. 2014;46(6):937-43.
6. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol. 2003;121(4):535-55.
7. Wu ZJ, Zhang YH, Wang LY, et al. The association between postoperative thrombocytopenia and outcome after coronary artery bypass grafting. Perfusion. 2020;35(2):117-23.
8. Kertai MD, Zhou S, Karhausen JA, et al. Platelet count as predictor of adverse events after coronary artery bypass grafting. Ann Thorac Surg. 2015;99(6):1867-74.
9. Dacey LJ, Munoz JJ, Johnson ER, et al. Effect of preoperative platelet count on post-coronary artery bypass grafting outcomes. Ann Thorac Surg. 2002;74(1):214-9.
10. Hedayati N, Yadav N, Shadrach B, et al. Postoperative thrombocytopenia and outcomes after cardiac surgery: a cohort study. Ann Thorac Surg. 2017;104(3):890-6.
11. Ozkok A, Ozel A, Karahan S, et al. Postoperative thrombocytopenia and acute kidney injury after cardiac surgery. Ren Fail. 2016;38(2):237-42.
12. Koster A, Zittermann A, Gummert JF, et al. Hemostatic factor alterations and neurologic outcomes in patients undergoing CABG. J Thorac Cardiovasc Surg. 2009;138(2):387-92.
13. O'Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery. Ann Thorac Surg. 2009;88(1 Suppl):S23-42.
14. Choi YJ, Jeong DS, Lee YT, et al. Postoperative thrombocytopenia as a prognostic factor after CABG. Korean J Thorac Cardiovasc Surg. 2016;49(3):172-177.
15. Zhang YH, Wang LY, Wu ZJ, et al. The association between postoperative thrombocytopenia and outcome after coronary artery bypass grafting. Perfusion. 2020;35(2):117-123.
16. McDonald CI, Fraser JF, Coombes JS, et al. Oxidative stress during extracorporeal circulation. Eur J Cardiothorac Surg. 2014;46(6):937-943.
17. Yuan SM. Platelet depletion in the post-cardiopulmonary bypass period. Blood Coagul Fibrinolysis. 2014;25(1):3–8.
18. Erdoes G, Kessler U, Litschi M, et al. Risk factors for early postoperative thrombocytopenia after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2012;26(5):845–850.
19. Kaw D, Malhotra D. Platelet dysfunction and renal injury. Clin J Am Soc Nephrol. 2006;1(6):1381–1389.
20. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol. 2003;121(4):535–555.
21. Dacey LJ, Munoz JJ, Johnson ER, et al. Effect of preoperative platelet count on post-coronary artery bypass grafting outcomes. Ann Thorac Surg. 2002;74(1):214-9.
22. Hedayati N, Yadav N, Shadrach B, et al. Postoperative thrombocytopenia and outcomes after cardiac surgery: a cohort study. Ann Thorac Surg. 2017;104(3):890-6.
23. Koster A, Zittermann A, Gummert JF, et al. Hemostatic factor alterations and neurologic outcomes in patients undergoing CABG. J Thorac Cardiovasc Surg. 2009;138(2):387-92.
24. O'Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models. Ann Thorac Surg. 2009;88(1 Suppl):S23-42.
25. George G, Hamon M, Shroff A. Platelet count and bleeding outcomes in cardiac surgery. Heart Lung Circ. 2015;24(3):211-217.
26. Demirtas S, Gungor H, Yilmaz R, et al. Mean platelet volume as a marker of postoperative complications in cardiac surgery. Braz J Cardiovasc Surg. 2016;31(3):239–243.